DUBLIN, Sept. 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019" report to their offering.
On the basis of type of technology, the global ablation technologies market has been divided into eight major segments, namely, light/laser, radiofrequency, electrical, ultrasound, microwave, cryotherapy, hydrothermal, and hydromechanical ablation technologies. The light/laser ablation technology segment accounted for the largest share of the global market in 2014. Furthermore, microwave ablation technology segment is expected to grow at the highest CAGR in the next five years, owing to various growth strategies followed by market players and technological advancements in the field of microwave ablation.
On the basis of type of application, the global ablation technologies market is classified into general surgery, cancer surgery, cardiovascular surgery, ophthalmological surgery, gynecological surgery, urological surgery, orthopedic application, cosmetic surgery, and other applications. The general surgery applications segment accounted for the largest share of the global market in 2014. Furthermore, the cosmetic surgery applications segment is expected to grow at the highest CAGR in the next five years, owing to growing demand for minimally invasive cosmetic surgery, increasing government funding for aesthetic surgical procedures, and rising medical tourism in emerging countries.
This report studies the global market over the forecast period of 2014 to 2019. The market is expected to reach -$2.41 billion by 2019, at CAGR of 9.6% from 2014 to 2019.
A number of factors such as the worldwide development of technologically advanced ablation devices, increase in aging population (which in turn is increasing the demand for age-related surgeries), growing prevalence of cancer and cardiovascular diseases, and rising preference for minimally invasive procedures are propelling the growth of the global ablation technologies market. However, ongoing healthcare reforms in the U.S., regulatory product recalls, and rising price pressure on market players are some major factors restraining the growth of this market. In addition to this, the stringent regulatory scenario in developed countries is the key challenge faced by market players in the market.
On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. In 2014, the global ablation technologies market was dominated by North America. A number of factors such as the high volume of minimally invasive surgical procedures, growing prevalence of cancer and cardiovascular diseases, government funding, and technological advancements are driving the growth of the market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019 due to factors such as large population base, increase in modernization of healthcare infrastructure, and rising government efforts to broaden the public access to minimally invasive surgeries in the Asia-Pacific countries.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview (Page No. - 43)
6 Industry Trends
7 Global Ablation Technologies Market, By Type
8 Global Ablation Technologies Market, By Product
9 Global Ablation Technologies Market, By Application
10 Ablation Technologies Market, By Geography
11 Competitive Landscape
12 Company Profiles
- Angiodynamics, Inc.
- Atricure, Inc.
- Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
- Boston Scientific Corporation
- Conmed Corporation
- Covidien PLC
- Medtronic, Inc.
- Olympus Corporation
- Smith & Nephew PLC
- St. Jude Medical, Inc.
For more information visit http://www.researchandmarkets.com/research/3tj9g7/ablation
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets